BIOTX.AI

biotxai-logo

Biotx.ai delivers next-generation biomarkers as a basis for decision support in precision medicine.

#People #Financial #Website #More

BIOTX.AI

Social Links:

Industry:
Artificial Intelligence Biotechnology Pharmaceutical

Founded:
2017-01-01

Address:
Berlin, Berlin, Germany

Country:
Germany

Website Url:
http://www.biotx.ai

Total Employee:
1+

Status:
Active

Email Addresses:
[email protected]

Total Funding:
0

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Domain Not Resolving Amazon Google Apps For Business Google Google Cloud


Current Employees Featured

marco-schmidt_image

Marco Schmidt
Marco Schmidt Managing Director & Chief Scientific Officer @ biotx.ai
Managing Director & Chief Scientific Officer
2017-09-01

joern-klinger_image

Joern Klinger
Joern Klinger Co-CEO and CTO @ biotx.ai
Co-CEO and CTO

charles-ravarani_image

Charles Ravarani
Charles Ravarani Chief Technology Officer @ biotx.ai
Chief Technology Officer
2020-01-01

Founder


joern-klinger_image

Joern Klinger

Investors List

f-st_image

FAST โ€”ย by GETTYLAB

FAST โ€”ย by GETTYLAB investment in Seed Round - biotx.ai

creative-destruction-lab_image

Creative Destruction Lab (CDL)

Creative Destruction Lab (CDL) investment in Non Equity Assistance - biotx.ai

startupbootcamp_image

Startupbootcamp

Startupbootcamp investment in Seed Round - biotx.ai

Official Site Inspections

http://www.biotx.ai

  • Host name: acd89244c803f7181.awsglobalaccelerator.com
  • IP address: 99.83.231.61
  • Location: Seattle United States
  • Latitude: 47.54
  • Longitude: -122.3032
  • Metro Code: 819
  • Timezone: America/Los_Angeles
  • Postal: 98108

Loading ...

More informations about "biotx.ai"

Biotx.ai

AI driven causal modeling at scale Efficacy prediction for drug discovery & development. Causal modeling is a proven method to predict success in clinical trials. It rests upon the same โ€ฆSee details»

biotx.ai - Crunchbase Company Profile & Funding

Where is biotx.ai 's headquarters? biotx.ai is located in Berlin, Berlin, Germany. Who invested in biotx.ai? biotx.ai has 4 investors including Oxonian Ventures โ€ฆSee details»

Our Team - Biotx.ai

His work with Chris and Tom opened his eyes to the possibilities of launching his own company, as well as to the limitation of traditional approaches to drug development: The inability to predict clinical efficacy. Solving this problem โ€ฆSee details»

Biotx.ai 2025 Company Profile: Valuation, Funding

Biotx.ai was founded in 2014. Where is Biotx.ai headquartered? Biotx.ai is headquartered in Potsdam, Germany. What is the size of Biotx.ai? Biotx.ai โ€ฆSee details»

biotx.ai - Funding, Financials, Valuation & Investors - Crunchbase

Organization. biotx.ai . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Funding Rounds 4. Investors 4. Funding. โ€ฆSee details»

biotx.ai - LinkedIn

Biotx.ai | 2,247 followers on LinkedIn. Unlocking the full therapeutic potential of the human genome through algorithms | biotx.ai delivers predictive biomarkers as a basis for decision support in ...See details»

Biotx.ai | AI enabled end-to-end drug development

Biotx.ai combines expert judgment, mechanistic validation and artificial intelligence Our expert drug selection committee , led by Jack Scannell , picks treatments most likely to go smoothly through regulatory processes, have โ€ฆSee details»

biotx.ai (biotx.ai GmbH) - startbase.com

Legal Entity: biotx.ai GmbH Location: Brandenburg Overview Company Funding Product Team News Is this your company? Profile is not claimed et. This profile is created by the Startbase โ€ฆSee details»

3 Questions to Biotx.ai: โ€œWith our AI platform, we have โ€ฆ

Biotx.ai, a company based in the Potsdam Science Park, manages to recognize complex patterns in genomic data with its AI platform, enabling it to make precise predictions about the efficacy of new therapies. Their approach could radically โ€ฆSee details»

Biotx - 2025 Company Profile, Funding & Competitors - Tracxn

Mar 28, 2025 Biotx is a seed company based in Berlin (Germany), founded in 2017 by Marco Schmidt and Joern Klinger. It operates as a Provider of AI-based platform for next-generation insights from genomic data. Biotx has raised an undisclosed amount in funding from Startupbootcamp and Merck Accelerator.See details»

biotx.ai (biotx.ai GmbH) - Startbase

Die neusten Erwähnungen von biotx.ai in Podcasts & Videos: Offene Jobs bei biotx.ai: Weitere Startups in der Nähe von biotx.ai. HEDERA. Startup 2020 Potsdam. HEDERA. โ€ฆSee details»

Biotx.ai, GmbH - Drug pipelines, Patents, Clinical trials - Synapse

Explore Biotx.ai, GmbH with its drug pipeline, therapeutic area, technology platform, 2 clinical trials, 3 news, and 5 literature, Technology Platform:Unknown, Drug ...See details»

biotx.ai - Products, Competitors, Financials, Employees, โ€ฆ

About biotx.ai. biotx.ai specializes in causal inference modeling and predictive analytics within the biotechnology and pharmaceutical sectors. The company offers services in drug discovery, โ€ฆSee details»

University of Toronto Entrepreneurship | Biotx.ai

Biotx.ai uses machine-learning techniques to analyze genomic data in combination with various sources of scientific literature to characterize polygenetic biomarkers and inform the development of novel diagnostics and โ€ฆSee details»

biotx.ai - Updates, News, Events, Signals & Triggers - Crunchbase

Aug 18, 2023 PRNewswire UK โ€” Simbec-Orion and biotx.ai launch strategic partnership to de-risk early-stage drug development with AI supported clinical trial design News โ€ข Aug 18, 2023 โ€ฆSee details»

biotx.ai - Company info. interviews, news - BiopharmaTrend

Feb 5, 2024 Biotx.ai delivers next-generation biomarkers as a basis for decision support in precision medicine. We use novel, state of the art, machine learning approaches specifically โ€ฆSee details»

Biotx.ai | Falling Walls

Biotx.ai is the first company to go from biobank data all the way to a clinical trial phase 2b. Purely computationally, they found a potential COVID-19 treatment via what they call synthetic clinical โ€ฆSee details»

Our Pipeline - Biotx.ai

Interaction-Based Feature Selection Algorithm Outperforms Polygenic Risk Score in Predicting Parkinsonโ€™s Disease Status Neutrophils cause critical illness in COVID-19 and reveal CDK6 โ€ฆSee details»

biotx.ai - Contacts, Employees, Board Members, Advisors & Alumni

Biotx.ai delivers next-generation biomarkers as a basis for decision support in precision medicine. New. Resources. Advanced Search. Start Free Trial ... Experience the new Crunchbase, โ€ฆSee details»

Applications - Biotx.ai

AI-Driven Diagnostics. Our complex polygenic markers allow for price diagnostics at scale. Away From Break and Fix. Traditionally diseases are treated when their effects become noticeable. โ€ฆSee details»

linkstock.net © 2022. All rights reserved